Valion Bio names CFO Lisa Wolf as president and COO after CEO exits Sep 1, 2026 08:01AM
Valion Bio Announces Changes to Management and Board of Directors Sep 1, 2026 08:00AM
Valion Bio sets 1-for-25 reverse split to meet Nasdaq rules Aug 27, 2026 08:31AM
Valion Bio Announces Reverse Stock Split Aug 27, 2026 08:30AM
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase Aug 13, 2026 10:00AM


Aug 12, 2026 09:32AM AFRRI begins government-funded Entolimod radiation injury study
Aug 12, 2026 09:29AM Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
Jul 20, 2026 01:30PM Sheba Medical Center to trial Valion Bio's Entolimod in cancer patients
Jul 14, 2026 07:45AM Valion Bio reports manufacturing scale-up and government talks for Entolimod
Jun 25, 2026 07:45AM AFRRI and NIAID complete protocol to test Valion Bio's Entolimod
Jun 11, 2026 07:45AM Valion Bio notes House committee directive on radiation countermeasures
May 14, 2026 04:32PM Velocity Bioworks secures exclusive license for BioScan-NMR platform
May 5, 2026 08:02AM Valion Bio receives $7 million NIAID funding for radiation syndrome drug
Apr 23, 2026 04:06PM Tivic Health rebrands to Valion Bio, changes ticker to VBIO